Pure Global

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers - Trial NCT05486455

Access comprehensive clinical trial information for NCT05486455 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital St. Joseph, Marseille, France and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05486455
Not yet recruiting
diagnostic test
Trial Details
ClinicalTrials.gov • NCT05486455
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers: a Real Life Study

Study Focus

Smoking

Low-dose chest CT scan

Interventional

diagnostic test

Sponsor & Location

Hospital St. Joseph, Marseille, France

Timeline & Enrollment

N/A

Oct 01, 2022

Oct 01, 2028

1000 participants

Primary Outcome

Positive Predictive Value (PPV)

Summary

Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification
 (version 1.1) for lung cancer screening among former and current smokers.

ICD-10 Classifications

Tobacco use
Exposure to tobacco smoke
Toxic effect: Tobacco and nicotine
Mental and behavioural disorders due to use of tobacco : harmful use
Drug use

Data Source

ClinicalTrials.gov

NCT05486455

Non-Device Trial